Astra IDL

Astra IDL, now known as AstraZeneca Pharma India Limited, is a leading pharmaceutical company in India that originated as a joint venture between the Swedish pharmaceutical giant Astra AB and IDL Chemicals. Established in 1979, the company focuses on the manufacturing, marketing, and distribution of innovative prescription medicines in therapeutic areas such as oncology, cardiovascular, renal, metabolism, and respiratory diseases. Following the global merger of Astra and Zeneca, and the subsequent buyout of IDL's stake by Astra AB in 2000, the entity was renamed to reflect its parentage. Today, it operates as a key subsidiary of AstraZeneca PLC, providing a wide range of life-changing medicines to patients across India. The company is publicly traded on the Indian stock exchanges and maintains a significant presence through its headquarters and manufacturing facilities in Bengaluru.